Conjugation of wildtype and hypoallergenic mugwort allergen Art v 1 to flagellin induces IL-10-DC and suppresses allergen-specific TH2-responses in vivo
暂无分享,去创建一个
P. Briza | S. Scheurer | S. Vieths | A. Reuter | S. Schülke | F. Ferreira | G. Gadermaier | M. Toda | A. Wangorsch | I. Pablos | Kirsten Kuttich | S. Wolfheimer | Nadine Duschek
[1] A. Bathke,et al. Cross‐sectional study on allergic sensitization of Austrian adolescents using molecule‐based IgE profiling , 2017, Allergy.
[2] P. Demoly,et al. The European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): A paediatric assessment , 2017, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[3] A. Wan,et al. Targeting Warburg Effect in Cancers with PEGylated Glucose , 2016, Advanced healthcare materials.
[4] M. Karas,et al. Quality Control of Biomedicinal Allergen Products – Highly Complex Isoallergen Composition Challenges Standard MS Database Search and Requires Manual Data Analyses , 2015, PloS one.
[5] Z. Pan,et al. An avian influenza A (H7N9) virus vaccine candidate based on the fusion protein of hemagglutinin globular head and Salmonella typhimurium flagellin , 2015, BMC Biotechnology.
[6] W. Bao,et al. mTORC1 Regulates Flagellin-Induced Inflammatory Response in Macrophages , 2015, PloS one.
[7] M. Zhong,et al. Flagellin-PAc Fusion Protein Inhibits Progression of Established Caries , 2015, Journal of dental research.
[8] N. Ravin,et al. Protection against Multiple Influenza A Virus Strains Induced by Candidate Recombinant Vaccine Based on Heterologous M2e Peptides Linked to Flagellin , 2015, PloS one.
[9] S. Kim,et al. Tetanus toxin fragment C fused to flagellin makes a potent mucosal vaccine , 2015, Clinical and experimental vaccine research.
[10] C. Akdis,et al. Novel immunotherapy vaccine development , 2014, Current opinion in allergy and clinical immunology.
[11] M. Prausnitz,et al. Microneedle delivery of an M2e-TLR5 ligand fusion protein to skin confers broadly cross-protective influenza immunity. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[12] S. Akira,et al. Prevention of Intestinal Allergy in Mice by rflaA:Ova Is Associated with Enforced Antigen Processing and TLR5-Dependent IL-10 Secretion by mDC , 2014, PloS one.
[13] Validation of the first treatment-specific questionnaire for the assessment of patient satisfaction with allergen-specific immunotherapy in allergic patients: the ESPIA questionnaire. , 2013, The Journal of allergy and clinical immunology.
[14] Y.M. Li,et al. Flagellin-PAc Fusion Protein is a High-efficacy Anti-caries Mucosal Vaccine , 2012, Journal of dentistry research.
[15] R. Vance,et al. NAIPs: Building an innate immune barrier against bacterial pathogens , 2012, BioEssays : news and reviews in molecular, cellular and developmental biology.
[16] C. Milne. Paediatric Assessment , 2012, International Journal of Pharmaceutical Medicine.
[17] S. Scheurer,et al. A fusion protein of flagellin and ovalbumin suppresses the TH2 response and prevents murine intestinal allergy. , 2011, The Journal of allergy and clinical immunology.
[18] Hao Xu,et al. The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus , 2011, Nature.
[19] J. Treanor,et al. Induction of a potent immune response in the elderly using the TLR-5 agonist, flagellin, with a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125, STF2.HA1 SI). , 2011, Vaccine.
[20] J. Treanor,et al. Safety and immunogenicity of a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125) in healthy young adults. , 2010, Vaccine.
[21] A. Gewirtz,et al. TLR5 or NLRC4 is necessary and sufficient for promotion of humoral immunity by flagellin , 2010, European journal of immunology.
[22] S. Scheurer,et al. Fusion protein of TLR5-ligand and allergen potentiates activation and IL-10 secretion in murine myeloid DC. , 2010, Molecular immunology.
[23] Marcius S Almeida,et al. Mapping the interactions between a major pollen allergen and human IgE antibodies. , 2010, Structure.
[24] S. Mizel,et al. A recombinant flagellin-poxvirus fusion protein vaccine elicits complement-dependent protection against respiratory challenge with vaccinia virus in mice. , 2010, Viral immunology.
[25] P. Briza,et al. Targeting the cysteine-stabilized fold of Art v 1 for immunotherapy of Artemisia pollen allergy. , 2010, Molecular immunology.
[26] Y. Suezer,et al. CD40 ligand-triggered human dendritic cells mount interleukin-23 responses that are further enhanced by danger signals. , 2010, Molecular immunology.
[27] S. Mizel,et al. Immunization of young African green monkeys with OprF epitope 8-OprI-type A- and B-flagellin fusion proteins promotes the production of protective antibodies against nonmucoid Pseudomonas aeruginosa. , 2009, Vaccine.
[28] S. Akira,et al. Immune responses of TLR5+ lamina propria dendritic cells in enterobacterial infection , 2009, Journal of Gastroenterology.
[29] S. Vieths,et al. Immune recognition of novel isoforms and domains of the mugwort pollen major allergen Art v 1. , 2009, Molecular immunology.
[30] V. Leb,et al. Characterization of HLA Class II/Peptide-TCR Interactions of the Immunodominant T Cell Epitope in Art v 1, the Major Mugwort Pollen Allergen1 , 2008, The Journal of Immunology.
[31] Hiroshi Kiyono,et al. Regulation of humoral and cellular gut immunity by lamina propria dendritic cells expressing Toll-like receptor 5 , 2008, Nature Immunology.
[32] P. Olliaro,et al. Ensuring sustained ACT production and reliable artemisinin supply , 2007, Malaria Journal.
[33] Y. Huang,et al. A West Nile virus recombinant protein vaccine that coactivates innate and adaptive immunity. , 2007, The Journal of infectious diseases.
[34] Y. Huang,et al. Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity. , 2007, Vaccine.
[35] P. Briza,et al. Pollen‐food syndromes associated with weed pollinosis: an update from the molecular point of view , 2006, Allergy.
[36] S. Mizel,et al. Flagellin Is an Effective Adjuvant for Immunization against Lethal Respiratory Challenge with Yersinia pestis , 2006, Infection and Immunity.
[37] Young Ran Kim,et al. A Bacterial Flagellin, Vibrio vulnificus FlaB, Has a Strong Mucosal Adjuvant Activity To Induce Protective Immunity , 2006, Infection and Immunity.
[38] S. Michalek,et al. Cellular Mechanisms of the Adjuvant Activity of the Flagellin Component FljB of Salmonella enterica Serovar Typhimurium To Potentiate Mucosal and Systemic Responses , 2005, Infection and Immunity.
[39] B. Bohle,et al. Antigen presentation of the immunodominant T-cell epitope of the major mugwort pollen allergen, Art v 1, is associated with the expression of HLA-DRB1 *01. , 2005, The Journal of allergy and clinical immunology.
[40] M. D. de Veer,et al. Flagellin acting via TLR5 is the major activator of key signaling pathways leading to NF-κB and proinflammatory gene program activation in intestinal epithelial cells , 2004, BMC Microbiology.
[41] R. Valenta,et al. Vaccines for birch pollen allergy based on genetically engineered hypoallergenic derivatives of the major birch pollen allergen, Bet v 1 , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[42] P. Briza,et al. Art v 1, the major allergen of mugwort pollen, is a modular glycoprotein with a defensin‐like and a hydroxyproline‐rich domain , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[43] Peter Kelemen,et al. The T Cell Response to Art v 1, the Major Mugwort Pollen Allergen, Is Dominated by One Epitope1 , 2002, The Journal of Immunology.
[44] R. Valenta. The future of antigen-specific immunotherapy of allergy , 2002, Nature Reviews Immunology.
[45] H. Behrendt,et al. [Geographic and time trends of pollen count due to beeches, grass and mugwort (Artemisia) in Germany]. , 2001, Pneumologie.
[46] Clement BordierO. Phase Separation of Integral Membrane Proteins in Triton X-114 Solution , 2001 .
[47] G. Papa,et al. An epidemiological survey on the allergological importance of some emerging pollens in Italy. , 2000, Journal of investigational allergology & clinical immunology.
[48] H. Towbin,et al. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[49] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.